Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q3 2022 · 10-Q
Revenue$620.60M$620.60M+11.0% vs Q3 2021 Net Income-$25.00M-$25.00MN/M vs Q3 2021 EPS Diluted-$0.28-$0.28N/M vs Q3 2021 Operating Income$74,100,000+16.5% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$12,400,000N/M Margins · derivedOperating margin11.9%+0.6 pt vs Q3 2021
Net margin-4.0%+0.1 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end